Tejas Savant

Stock Analyst at Morgan Stanley

(0.67)
# 2449
Out of 5,370 analysts
298
Total ratings
33.59%
Success rate
-9.79%
Average return
39 Stocks
Name Action PT Current % Upside Ratings Updated
CTKB Cytek Biosciences
Maintains: Equal-Weight
9 7
3.31 111.48% 9 May 28, 2025
TXG 10x Genomics
Maintains: Overweight
26 18
11.03 63.19% 14 May 19, 2025
ILMN Illumina
Maintains: Equal-Weight
136 100
90.09 11% 8 May 12, 2025
TEM Tempus AI
Maintains: Overweight
60 65
71.99 -9.71% 3 May 9, 2025
HOLX Hologic
Maintains: Equal-Weight
77 65
65.16 -0.25% 9 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
8 7
6.91 1.3% 2 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 9
10.26 -12.28% 12 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
17 10
7.4 35.14% 13 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
25 15
13.43 11.69% 17 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 5
2.15 132.56% 13 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
16 20
42.55 -53% 2 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
176 185
168.2 9.99% 13 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
245 250
159.4 56.84% 11 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
647 678
404.82 67.48% 14 Jan 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Equal-Weight
24 23
24.05 -4.37% 1 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
26 28
26.66 5.03% 12 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
32 21
4.92 326.83% 2 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
4 2
1.38 44.93% 11 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
4 3
1.27 136.22% 10 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
80 40
9.14 337.64% 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
26 26
n/a n/a 12 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 8
n/a n/a 11 Oct 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
52 55
n/a n/a 11 Aug 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
1
n/a n/a 1 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
6 6
0.72 733.33% 3 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 10
2.91 243.64% 8 May 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
3
3.5 -21.43% 6 Mar 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
11 5
6.45 -22.48% 12 Feb 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
11 10
2.02 395.05% 10 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
80 73
49.13 48.59% 9 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
5 2
n/a n/a 5 Jan 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
10 8
n/a n/a 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
10 5
n/a n/a 8 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
350 250
151.28 65.26% 1 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 5
n/a n/a 5 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
17 19
n/a n/a 3 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
18 17
n/a n/a 8 May 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
21 20
n/a n/a 2 Mar 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
35 65
n/a n/a 1 Feb 22, 2021